Literature DB >> 4116138

Biophysical and biochemical heterogeneity of purified hepatitis B antigen.

G R Dreesman, F B Hollinger, J R Suriano, R S Fujioka, J P Brunschwig, J L Melnick.   

Abstract

Hepatitis B antigen of the D (a+, d+, y-) subtype was purified from plasma of apparently healthy persons and from hepatitis patients. The original samples contained 20- and 42-nm particles and tubular forms (20-nm diameter). Ultracentrifugation during the purification procedure yielded pellets which were then treated at pH 2.4. Both the large, 42-nm Dane particles and the tubular forms were lost during the acid treatment of the pelleted particles, yielding a preparation containing a mixture of particles approximately 20 and 25 nm in diameter. This difference in size was substantiated in that two distinct molecular weights were calculated from high-speed equilibrium data, 3.6 x 10(6) and 4.5 x 10(6). Further heterogeneity was observed in that hepatitis B antigenic activity was present in purified particles with an isoelectric pH of 4.0 and also in those with a pH of 4.4. No significant differences were observed in the gross amino acid composition of purified antigen obtained from plasma of three different persons. (125)I-labeled, purified antigen was found to contain six distinct polypeptides with molecular weights ranging from 10,000 to 39,000.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4116138      PMCID: PMC356488     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Organ cultures inoculated with serum from a hepatitis patient with Au antigenemia.

Authors:  A B Jenson; R M McCombs; N Sakurada; J L Melnick
Journal:  Exp Mol Pathol       Date:  1970-10       Impact factor: 3.362

2.  Additional specificities of Australia antigen and the possible identification of hepatitis carriers.

Authors:  C Levene; B S Blumberg
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

3.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

4.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

5.  Virus-like particles in Australia-antigen-associated hepatitis.

Authors:  I D Gust; G Cross; J Kaldor; A A Ferris
Journal:  Lancet       Date:  1970-05-02       Impact factor: 79.321

6.  Evidence for virus-specific noncapsid proteins in poliovirus-infected HeLa cells.

Authors:  D F Summers; J V Maizel; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1965-08       Impact factor: 11.205

7.  Electrn microscopic observations on virus-like particles associated with SH antigen.

Authors:  P T Jokelainen; K Krohn; A M Prince; N D Finlayson
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

8.  Specificities of human antibodies to Australia antigen.

Authors:  V K Raunio; W T London; A I Sutnick; I Millman; B S Blumberg
Journal:  Proc Soc Exp Biol Med       Date:  1970-06

9.  Biophysical studies of vesicular stomatitis virus.

Authors:  R M McCombs; M B Melnick; J P Brunschwig
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

Review 10.  Australia (hepatitis-associated) antigen: physicochemical and immunological characteristics.

Authors:  G L Le Bouvier; R W McCollum
Journal:  Adv Virus Res       Date:  1970       Impact factor: 9.937

View more
  21 in total

Review 1.  Toward hepatitis B vaccines.

Authors:  A J Zuckerman; C R Howard
Journal:  Bull N Y Acad Med       Date:  1975-04

2.  Polypeptide composition of HBsag.

Authors:  E Mineva; M Teoharova; S Ditzov; S Todorov
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  Structure of common pili from Escherichia coli.

Authors:  J C McMichael; J T Ou
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

4.  Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen.

Authors:  D L Peterson; I M Roberts; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

5.  Inability to detect hepatitis B virus or specific antigens in transformed chimpanzee lymphocytes.

Authors:  C A Schable; B L Murphy; K R Berquist; C R Gravelle; J E Maynard
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

6.  Extrahepatic manifestations of hepatitis B virus infection: Addison's disease and myelofibrosis in a patient with persistent hepatitis B surface antigenemia.

Authors:  F Somlo; G R Berry
Journal:  Can J Infect Dis       Date:  1993-05

7.  Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw.

Authors:  R Chairez; F B Hollinger; J P Brunschwig; G R Dreesman
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

8.  New radioimmunoadsorbent method for detection of hepatitis B surface antigen.

Authors:  R P Moore; S K Carpenter; C T Swartzell; L A Schick
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

9.  Proteins of hepatitis B surface antigen.

Authors:  J W Shih; J L Gerin
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

10.  Hepatitis B antigen: antigenic sites related to human serum proteins revealed by affinity chromatography.

Authors:  A R Neurath; A M Prince; A Lippin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.